financetom
Business
financetom
/
Business
/
Hong Kong-listed Samsonite plans dual listing in hunt for investors
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hong Kong-listed Samsonite plans dual listing in hunt for investors
Mar 21, 2024 8:18 PM
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FTAI Infrastructure inks deal with Aramco Trading to boost oil supply to Texas terminal
FTAI Infrastructure inks deal with Aramco Trading to boost oil supply to Texas terminal
Jun 13, 2024
June 13 (Reuters) - Ground freight and logistics firm FTAI Infrastructure ( FIP ) said on Thursday that one of its subsidiaries has executed a multi-year terminal services agreement with the energy trading unit of Saudi Aramco , which includes the future receipt of new crude oil volumes at its Main Terminal in Texas. FTAI said the subsidiary, Jefferson Energy,...
Warby Parker Insider Sold Shares Worth $1,813,790, According to a Recent SEC Filing
Warby Parker Insider Sold Shares Worth $1,813,790, According to a Recent SEC Filing
Jun 13, 2024
05:35 PM EDT, 06/13/2024 (MT Newswires) -- Steven Clive Miller, Chief Financial Officer, on June 11, 2024, sold 109,210 shares in Warby Parker ( WRBY ) for $1,813,790. Following the Form 4 filing with the SEC, Miller has control over a total of 173,012 shares of the company, with 173,012 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1504776/000110465924071357/xslF345X03/tm2417245-1_4seq1.xml ...
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
Teva sues Corcept over mifepristone 'monopoly' for rare disorder
Jun 13, 2024
(Reuters) - Teva Pharmaceuticals sued rival drugmaker Corcept Therapeutics ( CORT ) in federal court in San Francisco on Thursday, accusing it of monopolizing the market for mifepristone-based Korlym, used to treat a rare hormonal disorder called Cushing's syndrome. The lawsuit said Corcept and specialty pharmacy Optime Care, the sole distributor of Korlym, orchestrated a multifaceted scheme to prolong Corcept's...
Mineralys Therapeutics Insider Sold Shares Worth $1,252,718, According to a Recent SEC Filing
Mineralys Therapeutics Insider Sold Shares Worth $1,252,718, According to a Recent SEC Filing
Jun 13, 2024
05:36 PM EDT, 06/13/2024 (MT Newswires) -- Adam Scott Levy, CFO and Secretary, on June 11, 2024, sold 96,815 shares in Mineralys Therapeutics ( MLYS ) for $1,252,718. Following the Form 4 filing with the SEC, Levy has control over a total of 255,462 shares of the company, with 255,462 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1933414/000193341424000027/xslF345X03/wk-form4_1718314405.xml ...
Copyright 2023-2024 - www.financetom.com All Rights Reserved